Babesia infection through blood transfusions: Reports received by the US Food and Drug Administration, 1997-2007

Clinical Infectious Diseases

Volumn 48, Issue 1, 2009, Pages 25-30

  Gubernot, Diane M ^a,d   Lucey, Charles T ^a   Lee, Karen C ^b   Conley, Gilliam B ^c   Holness, Leslie G ^a   Wise, Robert P ^b  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b U S PUBLIC HEALTH SERVICE   (United States)

^c Office of Compliance and Biologic Quality   (United States)

^d HFM 394 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BABESIOSIS; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CLINICAL ARTICLE; DISEASE SURVEILLANCE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PUBLIC HEALTH; RECIPIENT; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BABESIOSIS; BLOOD TRANSFUSION; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 57749113707     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/595010     Document Type: Article

References (26)

1. Homer MJ, Aguilar-Delfin I, Telford SR III, Krause PJ, Persing DH. Babesiosis. Clin Microbiol Rev 2000; 13:451-69.
2. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Disease Society of America. Clin Infect Dis 2006; 43:1089-134.
3. Hatcher JC, Greenberg PD, Antique J, Jimenez-Lucho VE. Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis 2001; 32:1117-25.
4. Hunfeld K-P, Hildebrandt A, Gray JS. Babesiosis: recent insights into an ancient disease. Int J Parasitol 2008; 38:1219-37.
5. Thompson C, Spielman A, Krause PJ. Coinfecting deer-associated zoonoses: Lyme disease, babesiosis, and ehrlichiosis. Clin Infect Dis 2001; 33:676-85.
6. Cable RG, Leiby DA. Risk and prevention of transfusion-transmitted babesiosis and other tick-borne diseases. Curr Opin Hematol 2003; 10:405-11.
7. Leiby DA, Chung APS, Gill JE, et al. Demonstrable parasitemia among Connecticut blood donors with antibodies to Babesia microti. Transfusion 2005; 45:1804-10.
8. Krause PJ, Spielman A, Telford SR III, et al. Persistent parasitemia after acute babesiosis. N Engl J Med 1998; 339:160-5.
9. Krause PJ, McKay K, Gadbaw J, et al. Increasing health burden of human babesiosis in endemic sites. Am J Trop Med Hyg 2003; 68:431-6.
10. Kjemtrup AM, Conrad PA. Human babesiosis: an emerging tick-borne disease. Int J Parasitol 2000; 30:1323-37.
11. American Association of Blood Banks. Blood donor history questionnaire. Available at: http://www.aabb.org/Content/Donate_Blood/ Donor_History_Questionnaires/AABB_Blood_Donor_History_Questionnaire/. Accessed 11 April 2008.
12. White DJ, Talarico J, Chang H-G, et al. Human babesiosis in New York State - review of 139 hospitalized cases and analysis of prognostic factors. Arch Intern Med 1998; 158:2149-54.
13. US Food and Drug Administration, Department of Health and Human Services. Current good manufacturing practice for blood and blood components. Code of Federal Regulations. Title 21, part 606.170(b). 2008:58.
14. US Food and Drug Administration. Biologic Product Deviation Reporting. Available at: http://www.fda.gov/cber/biodev/biodev.htm. Accessed 13 November 2008.
15. Krause PJ. Babesiosis diagnosis and treatment. Vector Borne Zoonotic Dis 2003; 3:45-51.
16. Rodgers SE, Mather TN. Human Babesia microti incidence and Ixodes scapularis distribution, Rhode Island, 1998-2004. Emerg Infect Dis 2007. Available at: http://www.cdc.gov/EID/content/13/4/633.htm. Accessed 6 June 2008.
17. Leiby DA, Gill JE. Transfusion-transmitted tick-borne infections: a cornucopia of threats. Transfus Med Rev 2004; 18:293-306.
18. Leiby DA. Babesiosis and blood transfusion: flying under the radar. Vox Sang 2006; 90:157-65.
19. McQuiston JH, Childs JE, Chamberland ME, Tabor E. Transmission of tick-borne agents of disease by blood transfusion: a review of known and potential risks in the United States. Transfusion 2000; 40:274-84.
20. Eberhard ML, Walker EM, Steurer FJ. Survival of infectivity of Babesia in blood maintained at 25 C and 2-4 C. J Parasitol 1995; 81:790-2.
21. Gerber MA, Shapiro ED, Krause PJ, Cable RG, Badon SJ, Ryan RW. The risk of acquiring Lyme disease or babesiosis from a blood transfusion. J Infect Dis 1994; 170:231-4.
22. New York State Department of Health. Communicable disease annual reports and related information. Available at: http://www.health.state.ny.us/statistics/ diseases/communicable/. Accessed 9 April 2008.
23. Connecticut Department of Public Health. Reported cases of disease: 1990-1999. Available at: http://www.ct.gov/dph/lib/dph/ CT_Disease_Cases_90_99_FNL.pdf. Accessed 9 April 2008.
24. Connecticut Department of Public Health. Reported cases of disease: 2000-2005. Available at: http://www.ct.gov/dph/lib/dph/ CT_Disease_Cases_00_05_FNL.pdf. Accessed 9 April 2008.
25. Connecticut Department of Public Health. Reported cases of disease by county: 2006. http://www.ct.gov/dph/lib/dph/CT_Disease_Cases_by_County_2006_FNL. pdf. Accessed 9 April 2008.
26. Whitaker BI, Sullivan M. The 2005 Nationwide Blood Collection and Utilization Survey Report. U.S. Department of Health and Human Services. 2005. Available at: http://www.hhs.gov/ophs/bloodsafety/index.html. Accessed 27 December 2007.